Company
We’re Horizon, a global biopharmaceutical company driven by a simple idea: we believe that science and compassion must work together to transform lives.
Medicines
Our pipeline is built with purpose. As we tackle often overlooked diseases, we’re committed to discovering solutions that boldly change the lives of our communities.
We offer a portfolio of 11 medicines for rare and rheumatic conditions
News
06/20/2019
Horizon Therapeutics plc Initiates MIRROR Randomized Controlled Trial Evaluating KRYSTEXXA® (pegloticase injection) in Combination with Methotrexate to Increase Response Rates and Duration of Therapy
06/12/2019
Horizon Therapeutics plc Highlights the Systemic Implications of Gout and the Need for Improved Patient Care Strategies with a Series of Presentations at EULAR 2019